It doesn't have enough ratings yet to judge what users think.
NucleoGenex is made and published by UFORIA Science. AppBrain is an independent app data site and isn't affiliated with UFORIA Science. The app name, icon, screenshots and description belong to UFORIA Science and are shown as published on the App Store.
About NucleoGenex
NucleoGenex was a business app developed by UFORIA Science. It was removed from the App Store Feb 18, 2026.
User Ratings
NucleoGenex was rated 4.50 out of 5 stars, based on 6 ratings.
App Information
NucleoGenex was free. The app size was 78.34 MB. The last available version was 9.2504.0. The last update was on May 1, 2025.
Technical Requirements
The app had a content rating of High Maturity. The app had been available on the App Store since December 2018.
| Price | Free |
| Rating | 4.50 based on 6 ratings |
| Version | 9.2504.0 |
| App size | 78.3 MB |
| Maturity | High Maturity |
Similar apps
Screenshots
Also available on Google Play
Changelog of NucleoGenex
No changelog data
Developer information for UFORIA Science
Address:
Comments on NucleoGenex for iOS
We don't have enough comments to show example comments. Please check back later.
Technologies used by NucleoGenex
Frequently asked questions about NucleoGenex
Is NucleoGenex free?
Yes. NucleoGenex is free on the App Store.
Is NucleoGenex still available?
No. NucleoGenex was removed from the App Store. We last saw it there Feb 18, 2026.
How large is the NucleoGenex download?
NucleoGenex is 78.34 MB to download.
Is NucleoGenex suitable for children?
App Store gives NucleoGenex a high maturity rating. It is meant for adults.
How do people rate NucleoGenex?
NucleoGenex scores 4.50 out of 5 stars, from 6 ratings on the App Store.
Who made NucleoGenex?
NucleoGenex was developed by UFORIA Science. It is listed in the business category on the App Store.
What are the best alternatives to NucleoGenex?
People looking at NucleoGenex also look at these business apps: Liv Labs Connect, LifePharm Share, GoRecruit, NOW Tech Connect, Z-Blends Mobile.